FBInvestor
Stocks / Travere Therapeutics Inc
Institutional Ownership

Travere Therapeutics Inc

CUSIP 89422G107COMTVTXQ1 2026

Institutional Holders
254
13F filers
Shares Held
94.80M
Aggregate institutional
Institutional Value
$2.77B
Q1 2026
Net New Holders
-15
42 new · 57 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions42
Increased90
Decreased93
Sold out57

Institutional Holders

254 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Janus Henderson Group PLC11.42M$339.25M+908.4KAdded
2Fmr LLC10.97M$325.86M+1.35MAdded
3Blackrock, Inc.7.79M$231.50M77.3KReduced
4State Street Corp4.96M$147.36M+203.3KAdded
5Armistice Capital, LLC4.90M$145.50M+1.13MAdded
6Perceptive Advisors LLC4.14M$123.08M135.6KReduced
7Nomura Asset Management International Inc.3.27M$97.17M503.1KReduced
8Geode Capital Management, LLC2.37M$70.41M+226.1KAdded
9Renaissance Technologies LLC1.97M$58.43M280.0KReduced
10Stephens Investment Management Group LLC1.80M$53.43M+76.8KAdded

244 more institutional holders on Premium

See every fund holding Travere Therapeutics Inc, with full quarter-over-quarter share changes.

Unlock all holders